APO Research
Talk to an analyst

APO RESEARCH · REPORT

PD-L1 and PIK3CA Testing

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).

PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.

PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.

PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.

Selected research

Industry Growth & Trends

Global PD-L1 and PIK3CA Testing Industry Growth and Trends Forecast to 2032

30 December 202588 pages

Choose your research edition.

Industry ResearchPD-L1 and PIK3CA Testing Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal PD-L1 and PIK3CA Testing Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal PD-L1 and PIK3CA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PD-L1 and PIK3CA Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal PD-L1 and PIK3CA Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.

Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).

PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.

Read the full market overview

PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.

PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.

According to APO Research, the global PD-L1 and PIK3CA Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

This report provides a structured, data-driven view of the global PD-L1 and PIK3CA Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PD-L1 and PIK3CA Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PD-L1 and PIK3CA Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PD-L1 and PIK3CA Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global PD-L1 and PIK3CA Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PD-L1 and PIK3CA Testing Market by Company

Agilent Technologies

Roche

QIAGEN

EntroGen

Amoy Diagnostics

ACCB Biotech

PD-L1 and PIK3CA Testing Segment by Type

PD-L1 Testing

PIK3CA Testing

PD-L1 and PIK3CA Testing Segment by Application

Hospital

Diagnostic Center

Others

PD-L1 and PIK3CA Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PD-L1 and PIK3CA Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of PD-L1 and PIK3CA Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global PD-L1 and PIK3CA Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global PD-L1 and PIK3CA Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global PD-L1 and PIK3CA Testing Market Share by Region (2021-2026) Table 4. Global PD-L1 and PIK3CA Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global PD-L1 and PIK3CA Testing Market Share by Region (2027-2032) Table 6. Global PD-L1 and PIK3CA Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global PD-L1 and PIK3CA Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2026) Table 9. Global PD-L1 and PIK3CA Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global PD-L1 and PIK3CA Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global PD-L1 and PIK3CA Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global PD-L1 and PIK3CA Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2026) Table 24. Global PD-L1 and PIK3CA Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global PD-L1 and PIK3CA Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. PD-L1 and PIK3CA Testing Industry Trends Table 37. PD-L1 and PIK3CA Testing Industry Drivers Table 38. PD-L1 and PIK3CA Testing Industry Opportunities and Challenges Table 39. PD-L1 and PIK3CA Testing Industry Restraints Table 40. Global PD-L1 and PIK3CA Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global PD-L1 and PIK3CA Testing Revenue Market Share by Company (2021-2026) Table 42. Global PD-L1 and PIK3CA Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global PD-L1 and PIK3CA Testing Key Company Headquarters & Area Served Table 44. Global PD-L1 and PIK3CA Testing Company, Product Type & Application Table 45. Global PD-L1 and PIK3CA Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global PD-L1 and PIK3CA Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Agilent Technologies Company Information Table 49. Agilent Technologies Business Overview Table 50. Agilent Technologies PD-L1 and PIK3CA Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Agilent Technologies PD-L1 and PIK3CA Testing Product Portfolio Table 52. Agilent Technologies Recent Development Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche PD-L1 and PIK3CA Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Roche PD-L1 and PIK3CA Testing Product Portfolio Table 57. Roche Recent Development Table 58. QIAGEN Company Information Table 59. QIAGEN Business Overview Table 60. QIAGEN PD-L1 and PIK3CA Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. QIAGEN PD-L1 and PIK3CA Testing Product Portfolio Table 62. QIAGEN Recent Development Table 63. EntroGen Company Information Table 64. EntroGen Business Overview Table 65. EntroGen PD-L1 and PIK3CA Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. EntroGen PD-L1 and PIK3CA Testing Product Portfolio Table 67. EntroGen Recent Development Table 68. Amoy Diagnostics Company Information Table 69. Amoy Diagnostics Business Overview Table 70. Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Amoy Diagnostics PD-L1 and PIK3CA Testing Product Portfolio Table 72. Amoy Diagnostics Recent Development Table 73. ACCB Biotech Company Information Table 74. ACCB Biotech Business Overview Table 75. ACCB Biotech PD-L1 and PIK3CA Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ACCB Biotech PD-L1 and PIK3CA Testing Product Portfolio Table 77. ACCB Biotech Recent Development Table 78. North America PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America PD-L1 and PIK3CA Testing Market Size by Country (2021-2026) & (US$ Million) Table 80. North America PD-L1 and PIK3CA Testing Market Share by Country (2021-2026) Table 81. North America PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America PD-L1 and PIK3CA Testing Market Share Forecast by Country (2027-2032) Table 83. Europe PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe PD-L1 and PIK3CA Testing Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe PD-L1 and PIK3CA Testing Market Share by Country (2021-2026) Table 86. Europe PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe PD-L1 and PIK3CA Testing Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Country (2021-2026) Table 91. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific PD-L1 and PIK3CA Testing Market Share Forecast by Country (2027-2032) Table 93. Latin America PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2021-2026) Table 96. Latin America PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America PD-L1 and PIK3CA Testing Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2021-2026) Table 101. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa PD-L1 and PIK3CA Testing Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. PD-L1 and PIK3CA Testing Product Image Figure 3. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global PD-L1 and PIK3CA Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global PD-L1 and PIK3CA Testing Market Share by Region: 2025 VS 2032 Figure 6. Global PD-L1 and PIK3CA Testing Market Share by Region (2021-2032) Figure 7. North America PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. PD-L1 Testing Image Figure 13. Global PD-L1 Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. PIK3CA Testing Image Figure 15. Global PIK3CA Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global PD-L1 and PIK3CA Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global PD-L1 and PIK3CA Testing Market Share by Type 2025 VS 2032 Figure 18. North America PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2032) Figure 19. Europe PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2032) Figure 21. Latin America PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Diagnostic Center Image Figure 26. Global Diagnostic Center Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global PD-L1 and PIK3CA Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global PD-L1 and PIK3CA Testing Market Share by Application 2025 VS 2032 Figure 31. North America PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2032) Figure 32. Europe PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2032) Figure 34. Latin America PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 PD-L1 and PIK3CA Testing Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America PD-L1 and PIK3CA Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America PD-L1 and PIK3CA Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America PD-L1 and PIK3CA Testing Market Share by Country (2021-2032) Figure 41. Europe PD-L1 and PIK3CA Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe PD-L1 and PIK3CA Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe PD-L1 and PIK3CA Testing Market Share by Country (2021-2032) Figure 44. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Country (2021-2032) Figure 47. Latin America PD-L1 and PIK3CA Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America PD-L1 and PIK3CA Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2021-2032) Figure 50. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • PD-L1 Testing
  • PIK3CA Testing
Applications
  • Hospital
  • Diagnostic Center
  • Others
Companies covered
  • Agilent Technologies
  • Roche
  • QIAGEN
  • EntroGen
  • Amoy Diagnostics
  • ACCB Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global PD-L1 and PIK3CA Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global PD-L1 and PIK3CA Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global PD-L1 and PIK3CA Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global PD-L1 and PIK3CA Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions PD-L1 and PIK3CA Testing Market Size (2021-2032)
  8. 1.5.1 North America PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate (2021-2032)
2 PD-L1 and PIK3CA Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 PD-L1 Testing
  3. 2.1.2 PIK3CA Testing
  4. 2.2 Global PD-L1 and PIK3CA Testing Market Size by Type
  5. 2.2.1 Global PD-L1 and PIK3CA Testing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global PD-L1 and PIK3CA Testing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global PD-L1 and PIK3CA Testing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global PD-L1 and PIK3CA Testing Market Size by Regions
  9. 2.3.1 North America PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa PD-L1 and PIK3CA Testing Market Size Breakdown by Type (2021-2026)
3 PD-L1 and PIK3CA Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Diagnostic Center
  4. 3.1.3 Others
  5. 3.2 Global PD-L1 and PIK3CA Testing Market Size by Application
  6. 3.2.1 Global PD-L1 and PIK3CA Testing Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global PD-L1 and PIK3CA Testing Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global PD-L1 and PIK3CA Testing Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global PD-L1 and PIK3CA Testing Market Size by Regions
  10. 3.3.1 North America PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa PD-L1 and PIK3CA Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 PD-L1 and PIK3CA Testing Industry Trends
  2. 4.2 PD-L1 and PIK3CA Testing Industry Drivers
  3. 4.3 PD-L1 and PIK3CA Testing Industry Opportunities and Challenges
  4. 4.4 PD-L1 and PIK3CA Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by PD-L1 and PIK3CA Testing Revenue (2021-2026)
  2. 5.2 Global PD-L1 and PIK3CA Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global PD-L1 and PIK3CA Testing Key Company Headquarters & Area Served
  4. 5.4 Global PD-L1 and PIK3CA Testing Company, Product Type & Application
  5. 5.5 Global PD-L1 and PIK3CA Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global PD-L1 and PIK3CA Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 PD-L1 and PIK3CA Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 PD-L1 and PIK3CA Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Agilent Technologies
  2. 6.1.1 Agilent Technologies Company Information
  3. 6.1.2 Agilent Technologies Business Overview
  4. 6.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Product Portfolio
  6. 6.1.5 Agilent Technologies Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche PD-L1 and PIK3CA Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Roche PD-L1 and PIK3CA Testing Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 QIAGEN
  14. 6.3.1 QIAGEN Company Information
  15. 6.3.2 QIAGEN Business Overview
  16. 6.3.3 QIAGEN PD-L1 and PIK3CA Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 QIAGEN PD-L1 and PIK3CA Testing Product Portfolio
  18. 6.3.5 QIAGEN Recent Developments
  19. 6.4 EntroGen
  20. 6.4.1 EntroGen Company Information
  21. 6.4.2 EntroGen Business Overview
  22. 6.4.3 EntroGen PD-L1 and PIK3CA Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 EntroGen PD-L1 and PIK3CA Testing Product Portfolio
  24. 6.4.5 EntroGen Recent Developments
  25. 6.5 Amoy Diagnostics
  26. 6.5.1 Amoy Diagnostics Company Information
  27. 6.5.2 Amoy Diagnostics Business Overview
  28. 6.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Product Portfolio
  30. 6.5.5 Amoy Diagnostics Recent Developments
  31. 6.6 ACCB Biotech
  32. 6.6.1 ACCB Biotech Company Information
  33. 6.6.2 ACCB Biotech Business Overview
  34. 6.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ACCB Biotech PD-L1 and PIK3CA Testing Product Portfolio
  36. 6.6.5 ACCB Biotech Recent Developments
7 North America
  1. 7.1 North America PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
  3. 7.3 North America PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
  3. 8.3 Europe PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
  3. 10.3 South America PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst